Biggest changeResults of Operations The following table presents data from our consolidated statements of operations as well as the percentage relationship to total net sales of items included in our statements of operations (dollars in thousands): Year Ended December 31, 2024 2023 Net sales from products $ 1,221,292 58.6 % $ 964,002 61.8 % Net sales from services 861,234 41.4 596,697 38.2 Net sales 2,082,526 100.0 1,560,699 100.0 Cost of product sales 618,136 29.7 447,708 28.7 Cost of service sales 223,010 10.7 157,538 10.1 Cost of sales 841,146 40.4 605,246 38.8 Gross margin 1,241,380 59.6 955,453 61.2 Selling, general and administrative 741,247 35.6 494,884 31.7 Research and development 441,593 21.2 303,719 19.5 Total operating expenses 1,182,840 56.8 798,603 51.2 Income from operations 58,540 2.8 156,850 10.0 Interest income, net 36,595 1.8 42,112 2.7 Other income (loss), net 286,369 13.8 (41,901) (2.7) Income before provision for income taxes 381,504 18.3 157,061 10.1 Provision for (benefit from) income taxes 4,470 0.2 (18,722) (1.2) Net income $ 377,034 18.1 % $ 175,783 11.3 % The following table presents our revenues disaggregated by geography (dollars in thousands): Year Ended December 31, 2024 2023 United States $ 1,775,194 85 % $ 1,335,516 86 % Other countries 307,332 15 225,183 14 Total $ 2,082,526 100 % $ 1,560,699 100 % International revenue increased as a percentage of revenue compared to the prior year, primarily driven by increased sales in our Americas region (i.e., Central America, South America, and Canada). 44 Table of Contents Net Sales Net sales by product line were as follows (dollars in thousands): Year Ended December 31, Dollar Change Percent Change 2024 2023 TASER segment: TASER Devices (Professional) $ 453,055 21.8 % $ 333,923 21.4 % $ 119,132 35.7 % Cartridges 246,766 11.8 193,285 12.4 53,481 27.7 Axon Evidence and Cloud Services 54,913 2.6 35,680 2.3 19,233 53.9 Extended Warranties 37,515 1.8 31,689 2.0 5,826 18.4 Other (1) 26,424 1.3 18,933 1.2 7,491 39.6 TASER segment 818,673 39.3 613,510 39.3 205,163 33.4 Software and Sensors segment: Axon Evidence and Cloud Services 808,256 38.8 566,003 36.3 242,253 42.8 Axon Body Cameras and Accessories 246,855 11.9 183,023 11.7 63,832 34.9 Axon Fleet Systems 104,890 5.0 121,842 7.8 (16,952) (13.9) Extended Warranties 66,141 3.2 55,154 3.5 10,987 19.9 Other (2) 37,711 1.8 21,167 1.4 16,544 78.2 Software and Sensors segment 1,263,853 60.7 947,189 60.7 316,664 33.4 Total net sales $ 2,082,526 100.0 % $ 1,560,699 100.0 % $ 521,827 33.4 % (1) TASER segment “Other” includes smaller categories, such as VR hardware, weapons training revenue such as revenue associated with our Master Instructor School, and TASER consumer device sales.
Biggest changeNet income of $377.0 million for the year ended December 31, 2024 included net realized and unrealized gains of $162.9 million related to our strategic investments, a net unrealized gain of $120.3 million related to our marketable securities, and interest income, net of $36.6 million. 40 Table o f Contents Results of Operations The following tab le presents data from our consolidated statements of operations and comprehensive income as well as the percentage relationship to total net sales of items included in our consolidated statements of operations and comprehensive income (dollars in thousands): Year Ended December 31, 2025 2024 Net sales from products $ 1,576,864 56.7 % $ 1,221,292 58.6 % Net sales from services 1,202,672 43.3 861,234 41.4 Net sales 2,779,536 100.0 2,082,526 100.0 Cost of product sales 809,303 29.1 618,136 29.7 Cost of service sales 312,108 11.2 223,010 10.7 Cost of sales 1,121,411 40.3 841,146 40.4 Gross margin 1,658,125 59.7 1,241,380 59.6 Operating expenses: Selling, general and administrative 1,035,893 37.3 741,247 35.6 Research and development 684,308 24.6 441,593 21.2 Total operating expenses 1,720,201 61.9 1,182,840 56.8 Income (loss) from operations (62,076) (2.2) 58,540 2.8 Interest income 75,431 2.7 43,693 2.1 Interest expense (94,238) (3.4) (7,098) (0.3) Other income, net 99,857 3.6 286,369 13.8 Income before provision for income taxes 18,974 0.7 381,504 18.4 Provision for (benefit from) income taxes (105,682) (3.8) 4,470 0.2 Net income $ 124,656 4.5 % $ 377,034 18.2 % The following table presents our revenues disaggregated by geography (dollars in thousands): Year Ended December 31, 2025 2024 United States $ 2,305,012 83 % $ 1,775,194 85 % Other countries 474,524 17 307,332 15 Total $ 2,779,536 100 % $ 2,082,526 100 % International revenue increased compared to the prior year 2024 comparative period, primarily driven by increased sales in our Americas region. 41 Table o f Contents Net Sales Net sales by product line were as follows (dollars in thousands): Year Ended December 31, Dollar Change Percent Change 2025 2024 Connected Devices segment: TASER (1) $ 913,883 32.9 % $ 750,141 36.0 % $ 163,742 21.8 % Personal Sensors (2) 397,035 14.2 316,938 15.2 80,097 25.3 Platform Solutions (3) 265,946 9.6 154,213 7.4 111,733 72.5 Total Connected Devices segment 1,576,864 56.7 1,221,292 58.6 355,572 29.1 Total Software and Services segment 1,202,672 43.3 861,234 41.4 341,438 39.6 Total net sales $ 2,779,536 100.0 % $ 2,082,526 100.0 % $ 697,010 33.5 % (1) 'TASER' includes TASER handles, cartridges and related extended warranties.
The open purchase orders represent both cancellable and non-cancellable purchase orders with key vendors, which are included in this table due to our strategic relationships with these vendors.
Open purchase orders represent both cancellable and non-cancellable purchase orders with key vendors, which are included in this table due to our strategic relationships with these vendors.
If an unfavorable ruling were to occur, it may cause a material adverse impact on the financial condition, results of operations or cash flows for the period in which the ruling occurs, or future periods. For additional details, refer to Note 13 in Part II, Item 8 of this Annual Report on Form 10-K.
If an unfavorable ruling were to occur, it may cause a material adverse impact on the financial condition, results of operations or cash flows for the period in which the ruling occurs, or future periods. For additional details, refer to Note 11 in Part II, Item 8 of this Annual Report on Form 10-K.
We regularly evaluate our real estate needs to identify opportunities to reduce long-term cash requirements where practicable. Purchase obligations include both open purchase orders and other purchase commitments, discussed further within Note 13 in Part II, Item 8 of this Annual Report on Form 10-K.
We regularly evaluate our real estate needs to identify opportunities to reduce long-term cash requirements where practicable. Purchase obligations include both open purchase orders and other purchase commitments, discussed further within Note 11 in Part II, Item 8 of this Annual Report on Form 10-K.
Additional provisions are made to reduce excess, obsolete or slow-moving inventories to their net realizable value. These provisions are based on our best estimate after considering historical demand, projected future 52 Table of Contents demand, inventory purchase commitments, industry and market trends, and a variety of other factors.
Additional provisions are made to reduce excess, obsolete or slow-moving inventories to their net realizable value. These provisions are based on our best estimate after considering historical demand, projected future demand, inventory purchase commitments, industry and market trends, and a variety of other factors.
Obligations related to our uncertain tax positions have been excluded from the table above because of the uncertainty surrounding the timing and final amounts of any settlement. For additional details, refer to Note 14 in Part II, Item 8 of this Annual Report on Form 10-K.
R efer to Note 10 in Part II, Item 8 of this Annual Report on Form 10-K for additional details. Obligations related to our uncertain tax positions have been excluded from the table above because of the uncertainty surrounding the timing and final amounts of any settlement.
Revenues are recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. Revenue is recognized net of allowances for returns. For additional discussion, refer to Note 2 in Part II, Item 8 of this Annual Report on Form 10-K.
Revenues are recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services. For additional discussion, refer to Note 2 in Part II, Item 8 of this Annual Report on Form 10-K.
For additional details, refer to Note 1 and Note 16 in Part II, Item 8 of this Annual Report on Form 10-K. 54 Table of Contents Contingencies and Accrued Litigation Expense We are subject to the possibility of various loss contingencies arising in the ordinary course of business, including product-related and other litigation.
For additional details, refer to Note 1 and Note 14 in Part II, Item 8 of this Annual Report on Form 10-K. Contingencies and Accrued Litigation Expense We are subject to the possibility of various loss contingencies arising in the ordinary course of business, including product-related and other litigation.
Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may vary. For additional details, r efer to Note 21 in Part II, Item 8 of this Annual Report on Form 10-K. 55 Table of Contents
Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may vary. For additional details, r efer to Note 19 in Part II, Item 8 of this Annual Report on Form 10-K. 53 Table o f Contents
In addition, our revolving credit facility (the "Credit Agreement') is available for additional working capital needs or investment opportunities. The Credit Agreement provides for a senior unsecured multi-currency revolving credit facility in an aggregate principal amount of up to $200.0 million, $30.0 million of which is available for the issuance of letters of credit.
In addition, our revolving credit facility (the “Credit Agreement”) is available for additional working capital needs or investment opportunities. The Credit Agreement provides for a senior unsecured multi-currency revolving credit facility in an aggregate principal amount of up to $300.0 million, $50.0 million of which is available for the issuance of letters of credit.
Stock-based compensation expense associated with the 2024 XSU awards is recognized over the requisite service period, which is considered the longest explicit, implicit or derived service period for each respective tranche.
Stock-based compensation expense associated with XSUs is recognized over the requisite service period, which is considered the longest explicit, implicit or derived service period for each respective tranche.
As of December 31, 2024, and 2023, respectively, no amounts were drawn under the Credit Agreement. Under the terms of the line of credit, available borrowings are reduced by outstanding letters of credit. As of December 31, 2024, we had letters of credit outstanding of approximately $7.8 million under the facility and available borrowing of $192.2 million.
As of December 31, 2025, and December 31, 2024, respectively, no amounts were drawn under the Credit Agreement. Under the terms of the line of credit, available borrowings are reduced by outstanding letters of credit. As of December 31, 2025, we had letters of credit outstanding of approximately $8.9 million under the facility and available borrowing of $291.1 million.
Our revenues for the year ended December 31, 2024 were $2.1 billion, an increase of $521.8 million, or 33.4%, from the comparable period in the prior year. We had income from operations of $58.5 million, compared to $156.9 million for the same period in the prior year.
Our revenues for the year ended December 31, 2025 were $2.8 billion , an increase of $697.0 million, or 33.5%, from the year ended December 31, 2024. We had loss from operations of $62.1 million for the year ended December 31, 2025, compared to income from operations of $58.5 million for the same period in the prior year.
We have adjusted for expenses that we believe are not indicative of our core operating results. To improve comparability, prior periods have been conformed to the current period presentation. We use these non-GAAP financial measures in evaluating our operating performance in comparison to prior periods.
We have adjusted for expenses that we believe are not indicative of our core operating results, including stock-based compensation expense and amortization of acquired intangible assets. To improve comparability, prior periods have been conformed to the current period presentation. Our management uses these non-GAAP financial measures in evaluating our operating performance in comparison to prior periods.
Refer to Note 12 in Part II, Item 8 of this Annual Report on Form 10‑K for additional details related to our Credit Agreement and outstanding letters of credit. We believe we have access to additional financing. However, there is no assurance that such funding will be available on terms acceptable to us, or at all.
Refer to Note 20 in Part II, Item 8 of this Annual Report on Form 10-K for additional details. 47 Table o f Contents We believe we have access to additional fina ncing. However, there is no assurance that such funding will be available on terms acceptable to us, or at all.
For a discussion and analysis of the year ended December 31, 2023 as compared to the year ended December 31, 2022, refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 27, 2024.
For discussion of the year ended December 31, 2024 as compared to the year ended December 31, 2023, refer to MD&A included in Part II, Item 7 of our amended 2024 Annual Report on Form 10-K/A for the year ended December 31, 2024, filed with the SEC on May 7, 2025.
Accordingly, the equity investments will be carried at cost less impairment. These investments will be subsequently remeasured to fair value upon observable price changes in an orderly transaction for the identical or similar investments.
Strategic Investments Our strategic investments are generally accounted for under the ASC 321 measurement alternative for equity securities without readily determinable fair values. Accordingly, the equity investments will be carried at cost less impairment. These investments are subsequently remeasured to fair value upon observable price changes in an orderly transaction for the identical or similar investments.
Any significant changes in these underlying assumptions may significantly affect our impairment conclusions and net book value of corresponding assets in our consolidated financial statements. Based on our annual impairment assessments in the fourth quarter of 2024, no goodwill or indefinite-lived intangible asset impairment was indicated.
Any significant changes in these underlying assumptions may significantly affect our impairment conclusions and net book value of corresponding assets in our consolidated financial statements. Based on our annual impairment assessments, no goodwill or indefinite-lived intangible asset impairment was indicated. For additional details, refer to Note 1 in Part II, Item 8 of this Annual Report on Form 10-K.
Management’s Discussion and Analysis of Financial Condition and Results of Operations Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our consolidated financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) provides the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results.
We also recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carry forwards. Our calculation of current and deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws.
Income Taxes We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We also recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carry forwards.
Valuation of Goodwill, Intangible and Long-lived Assets We evaluate whether events and circumstances have occurred that indicate the remaining estimated useful life of long-lived assets and identifiable intangible assets, excluding goodwill and intangible assets with indefinite useful lives, may warrant revision or that the remaining balance of these assets may not be recoverable.
For additional discussion, refer to Note 1 in Part II, Item 8 of this Annual Report on Form 10-K. 50 Table o f Contents Valuation of Goodwill, Intangible and Long-lived Assets We evaluate whether events and circumstances have occurred that indicate the remaining estimated useful life of long-lived assets and identifiable intangible assets, excluding goodwill and intangible assets with indefinite useful lives, may warrant revision or that the remaining balance of these assets may not be recoverable.
Provision for income taxes were as follows (dollars in thousands): Year Ended December 31, 2024 2023 Change Pre-tax income $ 381,504 $ 157,061 $ 224,443 Provision for (benefit from) income taxes 4,470 (18,722) 23,192 Effective tax rate 1.2 % (11.9) % 13.1 % Net Income We recorded net income of $377.0 million for the year ended December 31, 2024 compared to a net income of $175.8 million in 2023.
Provision for (benefit from) income taxes and effective tax rates were as follows (dollars in thousands): Year Ended December 31, 2025 2024 Change Income before provision for income taxes $ 18,974 $ 381,504 $ (362,530) Provision for (benefit from) income taxes (105,682) 4,470 (110,152) Effective tax rate (557.0) % 1.2 % Net Income We recorded net income of $124.7 million for the year ended December 31, 2025 compared to net income of $377.0 million for the year ended December 31, 2024.
As of December 31, 2024, we had $454.8 million of cash and cash equivalents, a decrease of $143.7 million from December 31, 2023. Refer below for further discussions related to the change in cash and cash equivalents.
As of the year ended December 31, 2025, we had $1.2 billion of cash and cash equivalents, an increase of $746.3 million from December 31, 2024. Refer below for further discussions related to the change in cash and cash equivalents.
Critical estimates used in valuing certain acquired intangible assets include, but are not limited to, significant assumptions with respect to time and resources required to recreate the assets acquired, actual and forecasted cash flows, long-term growth rates, market royalty rates, and discount rates associated, amongst other factors.
Additionally, in step acquisitions in which we acquire incremental equity interests that provide us control of a business, the previously held equity interest is remeasured to fair value at the date the controlling interest is acquired. 52 Table o f Contents Critical estimates used in valuing certain acquired intangible assets include, but are not limited to, significant assumptions with respect to time and resources required to recreate the assets acquired, actual and forecasted cash flows, long-term growth rates, market royalty rates, and discount rates associated, amongst other factors.
Investing activities Net cash used in investing activities was $490.6 million for the year ended December 31, 2024 compared to cash provided by investing activities of $12.5 million for the comparable period in the prior year.
Financing activities Net cash provided by financing activities was $1.3 billion for the year ended December 31, 2025 compared to cash used in financing activities of $45.4 million for the year ended December 31, 2024.
To a lesser extent, we also recognize revenue from training, professional services and other software and SaaS services. We apply the five-step model outlined in ASC 606, as discussed further in Note 1 in Part II, Item 8 of this Annual Report on Form 10-K.
Revenue Recognition We apply the five-step model outlined in ASC 606, as discussed further in Note 1 in Part II, Item 8 of this Annual Report on Form 10-K. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in ASC 606.
Net income per basic share was $4.98 and diluted net income per share was $4.80 for 2024, compared to net income per basic share of $2.37 and diluted net income per share of $2.33 for 2023.
Net income per basic share was $1.60 and diluted net income per share was $1.51 for the year ended December 31, 2025, compared to net income per basic share of $4.98 and diluted net income per share of $4.80 for the year ended December 31, 2024.
Our performance-based restricted stock units include eXponential stock units ( “ XSUs ” ) granted under the Axon Enterprise, Inc. 2024 Employee eXponential Stock Plan (the “ 2024 Employee XSP ” ) and the 2024 CEO Performance Award discussed further in Note 1 in Part II, Item 8 of this Annual Report.
Amended and Restated 2022 Stock Incentive Plan (the “Amended 2022 Plan”) and grants of eXponential stock units (“XSUs”) under the Axon Enterprise, Inc. Employee eXponential Stock Plan (the “Employee XSP”) and the CEO Performance Award, each of which is discussed further in Note 1 in Part II, Item 8 of this Annual Report.
For additional discussion, refer to Note 1 in Part II, Item 8 of this Annual Report on Form 10-K.
Refer to Note 10 in Part II, Item 8 of this Annual Report on Form 10-K for additional details. In addition, we had approximately $81.1 million aggregate principal amount of 2027 Notes outstanding as of December 31, 2025 .
Our MD&A should be read in conjunction with the other sections of this Annual Report on Form 10-K, including “Part I, Item 1A - Risk Factors” and “Part II, Item 8 - Financial Statements and Supplementary Data.” The various sections of our MD&A contain a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this filing.
For definitions and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures, refer to “Non-GAAP Measures” within this Annual Report on Form 10-K. The various sections of our MD&A contain forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risk factors described throughout this filing.
The tables in the MD&A sections below are derived from exact numbers and may have immaterial rounding differences. Our MD&A discusses our results of operations for the year ended December 31, 2024 as compared to the year ended December 31, 2023.
MD&A discusses our results of operations for the year ended December 31, 2025 as compared to the year ended December 31, 2024.
As a percentage of net sales, gross margin for the Software and Sensors segment decreased to 60.2% from 61.6% for the years ended December 31, 2024 and 2023, respectively. Within the Software and Sensors segment, hardware gross margin was 37.7% for the year ended December 31, 2024, compared to 45.8% for the same period in 2023.
Gross Margin As a percentage of net sales, gross margin for the Connected Devices seg ment decreased to 48.7% from 49.4% for the years ended December 31, 2025 and 2024, respectively. Adjusted gross margin for the Connected Devices segment w as 51.2% for the year ended December 31, 2025, compared to 53.6% for the year ended December 31, 2024.
Critical Accounting Estimates We have identified the following accounting estimates as critical to our business operations and the understanding of our results of operations.
For additional details, refer to Note 12 in Part II, Item 8 of this Annual Report on Form 10-K. Critical Accounting Estimates We have identified the following accounting estimates as critical to our business operations and the understanding of our results of operations.
Interest Income, Net Interest income, net, was as follows (in thousands): Year Ended December 31, 2024 2023 Interest income $ 43,693 $ 49,107 Interest expense (7,098) (6,995) Total interest income, net $ 36,595 $ 42,112 The decrease in interest income for the year ended December 31, 2024 is primarily related to lowe r balances of available-for-sale securities during the year.
Interest Income (Loss), Net Interest income (loss), net, was as follows (in thousands): Year Ended December 31, 2025 2024 Interest income (1) $ 75,431 $ 43,693 Interest expense (2) (94,238) (7,098) Total interest income (loss), net $ (18,807) $ 36,595 (1) Interest income increased in comparison t o the year ended December 31, 2024 comparable period primarily as a result of higher balances of available-for-sale securities during the year.
Net sales for the TASER segment for the year ended December 31, 2024 increased $205.2 million, or 33.4%, as compared to the prior year, primarily due to an increase of $119.1 million in TASER devices and an increase of $53.5 million in cartridge revenue. The increase is primarily related to continued adoption of our newest device, TASER 10.
Net sales for the Connected Devices segment increased 29.1% for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase of $163.7 million in TASER is primarily driven by higher TASER 10 handle and cartridge volume.
Excluding the impacts of stock-based compensation expense and intangibles amortization, service adjusted gross margin increased to 75.8% for the year ended December 31, 2024, compared to 73.6% for the same period in 2023, due to higher software revenue mix.
The decrease was primarily driven by higher stock-based compensation expense and acquired intangibles amortization. Adjusted gross margin for the Software and Services segment increased to 77.5% for the year ended December 31, 2025, compared to 76.8% for the year ended December 31, 2024. The increase was primarily driven by higher software mix.
For additional details relating to our valuation techniques, refer to Note 1 and Note 8 in Part II, Item 8 of this Annual Report on Form 10-K. Business Combinations When we acquire a business, we allocate the purchase consideration to the liabilities assumed, intangible assets and other assets acquired based on their estimated respective fair values.
Business Combinations When we acquire a business, we allocate the purchase consideration to the liabilities assumed, intangible assets and other assets acquired based on their estimated respective fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill.
Included in the non-cash items were $382.6 million in stock-based compensation expense, $283.2 million in fair value adjustments for the realized and unrealized gains (losses) on our strategic investments and marketable securities, $48.4 million in depreciation and amortization expense and $85.1 million in deferred income taxes.
Primary drivers of the non-cash items include $634.2 million of stock-based compensation expense for employee equity programs, $83.2 million of depreciation and amortization and $38.9 million of debt inducement expense related to the induced conversion for our 2027 Notes, partially offset by $140.0 million in fair value adjustments for net realized and unrealized gains and losses on our strategic investments and marketable securities and $82.7 million for deferred income taxes.
For additional details, refer to Note 14 in Part II, Item 8 of this Annual Report on Form 10-K. Stock-Based Compensation We have historically utili zed stock-based compensation for key employees and non-employee directors as a means of attracting and retaining talented personnel.
As a result, we have no 2027 Notes outstanding following settlement of the aforementioned redemption. Refer to Note 10 and Note 20 in Part II, Item 8 of this Annual Report on Form 10-K for additional details.
The increase in the aggregate number of users and growing adoption of our premium add-on features by existing customers drove the majority of the increase in Axon Evidence and cloud services revenue of $242.3 million. Axon Body cameras and accessories revenue increased $63.8 million due to higher unit sales.
Net sales for the Software and Services segment increased 39.6% for the year ended December 31, 2025 as compared to the year ended December 31, 2024. The increase in the aggregate number of users and growing adoption of our premium add-on features by existing customers drove the majority of the increase of $341.4 million.
The net investing cash outflow is driven by $621.8 million related to acquiring two previously held strategic investments, $113.4 million for strategic investments, and $78.8 million for purchases of property and equipment, net of proceeds, partially offset by $1.0 billion of proceeds from calls, maturities and sales of available-for-sale investments, less purchases of $680.0 million.
The cash outflow was partially offset by $1.8 billion of proceeds from calls, maturities and sales of available-for-sale and marketable securities investments and $376.9 million of proceeds from the sale and liquidation of strategic investments. The increase in net cash outflow compared to prior period is primarily driven by greater available-for-sale and strategic investment activity in the current period.
Stock-based compensation expense increased $132.0 million in comparison to the prior year, which was primarily related to the 2024 Employee XSP and the 2024 CEO Performance Award that were approved by shareholders in the 2024 Annual Meeting of Shareholders and increased headcount.
Stock-based compensation expense, excluding the impact of non-recurring severance costs, increased $106.6 million in comparison to the prior year December 31, 2024, which was primarily related to an increase in headcount and a full year of expense recognized in the current year for grants of Employee XSP and the CEO Performance Award (as defined below), compared to a partial year of expense recognized in the prior year.
The $16.5 million increase in “Other” revenue was primarily driven by demand for other product offerings within the Software and Sensors segment. Gross Margin As a percentage of net sales, gross margin for the TASER segment decreased to 58.6% from 60.6% for the years ended December 31, 2024 and 2023, respectively.
The decrease in gross margin and adjusted gross margin is primarily driven by higher mix of Platform Solutions revenue and global tariffs. As a percentage of net sales, gross margin for the Software and Services s egment decreased to 74.0% from 74.1% for the years ended December 31, 2025 and 2024, respectively.
The change in fair value adjustments on strategic investments and marketable securities was primarily driven by the realized gains on the acquisition of two previously held strategic investments, an observable price change for an existing strategic investment and related warrants, and fair value gains for our marketable securities.
The realized and unrealized gains on our strategic investments and related warrants were primarily related to an observable price change and subsequent sale for one of our strategic investments and a liquidation event for a separate strategic investment.
Additionally, if a qualitative assessment identifies impairment indicators, then the equity investments must be evaluated for impairment and written down to fair value in the event carrying value exceeds fair value. The debt strategic investment and the associated embedded derivatives are accounted for utilizing the fair value option and remeasured through earnings on a periodic basis.
Additionally, if a qualitative assessment identifies impairment indicators, then the equity investments must be evaluated for impairment and written down to fair value in the event carrying value exceeds fair value. For additional details relating to our valuation techniques, refer to Note 1 and Note 7 in Part II, Item 8 of this Annual Report on Form 10-K.
Sales and marketing expense increased $17.1 million in comparison to the prior year, which was primarily attributable to increased commissions of $12.4 million and an increase of $4.7 million related to in-person events.
Sales and marketing expense increased $17.5 million in comparison to the prior year December 31, 2024 comparable period, which was primarily attributable to increased commissions. Other SG&A expenses increased $47.4 million in comparison to the prior year, partially driven by $11.9 million in increased travel expenses.
Other R&D expenses increased $17.6 million, primarily related to increased professional and consulting expenses related to the launch of new products of $6.6 million, and increased internal cloud storage and service costs related to software product development of $3.9 million.
Other R&D expenses increased $56.3 million in comparison to the prior year December 31, 2024, partially driven by an increase in professional and consulting expenses of $24.9 million related to the development of new products.
A reconciliation of GAAP to the non-GAAP financial measures is presented below. • EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense, investment interest income, income taxes, depreciation and amortization. • Adjusted EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense; investment interest income; income taxes; depreciation; amortization; noncash stock-based compensation expense; fair value adjustments related to strategic investments and marketable securities; transaction and integration costs related to strategic investments and acquisitions including adjustments related to the foreign currency impact of acquired intercompany balances that were unsettled as of the reporting date and plan to be settled in the near term; inventory step-up amortization related to acquisitions; certain litigation costs and recoveries related to (1) antitrust cases we consider to be non-recurring and outside of our core operating results and (2) litigation matters for acquired companies that were unresolved at the date of the acquisition; and other unusual, non-recurring pre-tax items that are not considered representative of our underlying operating performance (listed in the tables below). • Adjusted gross margin (most comparable GAAP measure: Gross margin) – Gross margin before noncash stock-based compensation expense, amortization of acquired intangible assets, and inventory step-up amortization related to acquisitions. 48 Table of Contents Although these non-GAAP financial measures are not consistent with GAAP, we believe investors will benefit by referring to these non-GAAP financial measures when assessing our operating results, as well as when forecasting and analyzing future periods.
A reconciliation of GAAP to the non-GAAP financial measures is presented below. • EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense, investment interest income, income taxes, depreciation and amortization. • Adjusted EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense; investment interest income; income taxes; depreciation; amortization; noncash stock-based compensation expense; fair value adjustments related to strategic investments, marketable securities, and mark-to-market on our non-qualified deferred compensation liabilities; debt inducement expense associated with the early repurchase of a portion of our 2027 Notes; non-recurring severance costs, including employee cash payments, equity, and related benefits; transaction and integration costs related to strategic investments and acquisitions, including the change in fair value of contingent consideration arrangements; payroll taxes related to Employee XSP vesting and 2018 CEO Performance Award option exercises; costs (or subsequent recoveries of prior costs) related to certain legal or regulatory matters we consider outside of our core operating activities; losses incurred as a result of the disposal, abandonment, and impairment of property, equipment and intangible assets; and inventory step-up amortization related to acquisitions. • Adjusted gross margin (most comparable GAAP measure: Gross margin) – Gross margin before noncash stock-based compensation expense; amortization of acquired intangible assets; non-recurring severance costs, including employee cash payments, equity, and related benefits; payroll taxes related to Employee XSP vesting; and inventory step-up amortization related to acquisitions.
Gross margin dollars increased $285.9 million but decreased as a percentage of revenue to 59.6% from 61.2% compared to the same period in the prior year. The decrease was primarily driven by higher stock-based compensation expense and amortization of acquired intangibles.
Gross margin dollars increased $416.7 million and increased as a percentage of revenue to 59.7% from 59.6% compared to the year ended December 31, 2024. Adjusted gross margin decreased to 62.6% for the year ended December 31, 2025 compared to 63.2% for the year ended December 31, 2024.
For additional details, refer to Note 1 in Part II, Item 8 of this Annual Report on Form 10-K. 53 Table of Contents Income Taxes We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction.
For additional details, refer to Note 12 in Part II, Item 8 of this Annual Report on Form 10-K. 51 Table o f Contents Stock-Based Compensation Our stock-based compensation program includes grants of service-based restricted stock units ( “ RSUs ” ), performance-based restricted stock units ( “ PSUs ” ), and performance-based stock options ( “ stock options ” ) under the Axon Enterprise, Inc.
On or after December 22, 2025, we may redeem for cash all or any portion of the notes in accordance with the optional redemption terms of the convertible debt agreement. For additional details, refer to Note 12 in Part II, Item 8 of this Annual Report on Form 10-K.
Therefore, the Notes were classified as current liabilities within our consolidated balance sheet as of December 31, 2025 and have been presented within short-term above. Refer to Note 10 and Note 20 in Part II, Item 8 of this Annual Report on Form 10-K for additional details.
Selling, General and Administrative Expenses SG&A expenses (dollars in thousands): Year Ended December 31, Dollar Change Percent Change 2024 2023 Salaries, benefits and bonus $ 251,139 $ 215,100 $ 36,039 16.8 % Sales and marketing 108,954 91,868 17,086 18.6 Stock-based compensation 190,561 58,533 132,028 225.6 Other 190,593 129,383 61,210 47.3 Total selling, general and administrative expenses $ 741,247 $ 494,884 $ 246,363 49.8 % SG&A expenses as a percentage of net sales 35.6 % 31.7 % Salaries, benefits and bonus expense increased $36.0 million in comparison to the prior year, which was primarily attributable to an increase in headcount and higher wages.
Selling, General and Administrative Expenses SG&A expenses (dollars in thousands): Year Ended December 31, Dollar Change Percent Change 2025 2024 Total selling, general and administrative expenses $ 1,035,893 $ 741,247 $ 294,646 39.8 % As a percentage of net sales 37.3 % 35.6 % We incurred non-recurring severance costs during the three months ended December 31, 2025 of $28.7 million, which consisted of stock-based compensation, cash payments and employee benefits. 42 Table o f Contents Stock-based compensation expense, excluding the impact of non-recurring severance costs, increased $127.8 million in comparison to the prior year December 31, 2024 comparable period, which was primarily related to an increase in headcount and a full year of expense recognized in the current year for grants of Employee XSP and the CEO Performance Award (as defined below), compared to a partial year of expense recognized in the prior year.